PATENT CLAIM ANALYSIS

Application Number: 16283743
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["514", "001000"]

Abstract:
The disclosed invention generally relates to treatment and/or prevention of symptoms associated with cannabinoid responsive diseases and disorders in subjects in need thereof, as well as the method of administering therapeutically-effective amount of a pharmaceutical compound containing cannabinoids. The disclosed invention further relates to pharmaceutical compounds for treating and/or preventing symptoms associated with said diseases and disorders.

Claim (Index 30):
The compound of  claim 28 , where said one or more THC isomers and one or more CBD isomers are in the quantity ranging from 0.5 mg to 40 mg THC and 2.6 mg to 3,700 mg CBD.

Metadata:
- Claim Count in Document: 80.0
- Percentile: 99.0
- Lexical Diversity: 1.42857
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15789998', '14163019', '12087847', '15554209', '10468041']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8190907309002488
- 35 USC 102 Novelty (BERT): 0.6128832548326245
- Combined Prediction Score: 0.7984699832934864
- Mean Citation Score: 437.63076
- Max Citation Score: 652.6821
- Similarity Product: 467.1831087024093

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test